Literature DB >> 14671133

Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.

Shih-Heng Chen1, Angela Pearson, Donald M Coen, Shun-Hua Chen.   

Abstract

Thymidine kinase-negative mutants of herpes simplex virus did not reactivate from latency in mouse trigeminal ganglia, even when their latent viral loads were comparable to those that permitted reactivation by wild-type virus. Thus, reduced establishment of latency does not suffice to account for the failure to reactivate.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14671133      PMCID： PMC303395          DOI： 10.1128/jvi.78.1.520-523.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  34 in total

1.  Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus.

Authors:  Shun-Hua Chen; Lily Yeh Lee; David A Garber; Priscilla A Schaffer; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Identification, localization, and regulation of expression of the UL24 protein of herpes simplex virus type 1.

Authors:  Angela Pearson; Donald M Coen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Herpes simplex virus thymidine kinase expression in infection of the trigeminal ganglion.

Authors:  R B Tenser; M E Dunstan
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

4.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.

Authors:  R B Tenser; R L Miller; F Rapp
Journal:  Science       Date:  1979-08-31       Impact factor: 47.728

5.  ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.

Authors:  S H Chen; D A Garber; P A Schaffer; D M Knipe; D M Coen
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

8.  Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.

Authors:  Anthony Griffiths; Shun-Hua Chen; Brian C Horsburgh; Donald M Coen
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Recurrent acyclovir-resistant herpes simplex in an immunocompromised patient: can strain differences compensate for loss of thymidine kinase in pathogenesis?

Authors:  B C Horsburgh; S H Chen; A Hu; G B Mulamba; W H Burns; D M Coen
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

10.  Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity.

Authors:  R W Price; A Khan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441
View more
  13 in total

1.  Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.

Authors:  Dongli Pan; Donald M Coen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.

Authors:  Nolwenn Poccardi; Antoine Rousseau; Oscar Haigh; Julie Takissian; Thierry Naas; Claire Deback; Louise Trouillaud; Mohammad Issa; Simon Roubille; Franceline Juillard; Stacey Efstathiou; Patrick Lomonte; Marc Labetoulle
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 4.  Progress and problems with the use of suicide genes for targeted cancer therapy.

Authors:  Zahra Karjoo; Xuguang Chen; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2015-05-22       Impact factor: 15.470

5.  Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.

Authors:  Alexander M Rowe; Hongming Yun; Benjamin R Treat; Paul R Kinchington; Robert L Hendricks
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

6.  Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.

Authors:  Chih-Yu Huang; Hui-Wen Yao; Li-Chiu Wang; Fang-Hsiu Shen; Sheng-Min Hsu; Shun-Hua Chen
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

7.  Efficient reactivation of latent herpes simplex virus from mouse central nervous system tissues.

Authors:  Shih-Heng Chen; Hui-Wen Yao; Wen-Yen Huang; Kuei-Sen Hsu; Huan-Yao Lei; Ai-Li Shiau; Shun-Hua Chen
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

8.  Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.

Authors:  Kening Wang; Gowtham Mahalingam; Susan E Hoover; Erik K Mont; Steven M Holland; Jeffrey I Cohen; Stephen E Straus
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

9.  Net -1 frameshifting on a noncanonical sequence in a herpes simplex virus drug-resistant mutant is stimulated by nonstop mRNA.

Authors:  Dongli Pan; Donald M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

10.  Tranylcypromine reduces herpes simplex virus 1 infection in mice.

Authors:  Hui-Wen Yao; Pin-Hung Lin; Fang-Hsiu Shen; Guey-Chuen Perng; Yuk-Ying Tung; Sheng-Min Hsu; Shun-Hua Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.